Parkinson's Disease: A Neurodegenerative Disease Particularly Amenable to Gene Therapy
Open Access
- 30 June 2000
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (6) , 494-496
- https://doi.org/10.1006/mthe.2000.0078
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Delivery of a GDNF Gene into the Substantia Nigra after a Progressive 6-OHDA Lesion Maintains Functional Nigrostriatal ConnectionsExperimental Neurology, 2000
- Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian ratGene Therapy, 1999
- Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's diseaseAnnals of Neurology, 1999
- Behavioral and Cellular Protection of Rat Dopaminergic Neurons by an Adenoviral Vector Encoding Glial Cell Line-Derived Neurotrophic FactorExperimental Neurology, 1998
- Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in ratsProceedings of the National Academy of Sciences, 1997
- Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson diseaseProceedings of the National Academy of Sciences, 1997
- Dopaminergic Neurons Protected from Degeneration by GDNF Gene TherapyScience, 1997
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: Role of mesencephalic gliaJournal of Neuroscience Research, 1991